BREAST CANCER, EARLY STAGE

Neoadjuvant treatment with docetaxel plus lapatinib (L), trastuzumab (T), or both followed by an anthracycline based chemotherapy in HER2-positive breast cancer: Results of the randomised phase II EORTC 10054 study

H. Bonnefoi